Cargando…

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?

Detalles Bibliográficos
Autor principal:	Alliot, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361381/ https://www.ncbi.nlm.nih.gov/pubmed/16523197 http://dx.doi.org/10.1038/sj.bjc.6603032

Ejemplares similares

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
por: Cold, S, et al.
Publicado: (2005)

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Alliot, C
Publicado: (2004)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Alliot, C, et al.
Publicado: (2004)

Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
por: Hatzipanagiotou, Maria Eleni, et al.
Publicado: (2023)

Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Alliot, C
Publicado: (2006)

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
por: Alliot, C
Publicado: (2004)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Smoking cessation before initiation of chemotherapy in metastatic non-small cell lung cancer: influence on prognosis
por: Linhas, Ana Rita Diegues, et al.
Publicado: (2018)

Comment on “Influence of Orotate Phosphoribosyl Transferase Levels on Tumor Prognosis and Response to Chemotherapy”
por: Kapoor, Shailendra
Publicado: (2012)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial
por: Zhu, Si‐Yuan, et al.
Publicado: (2021)

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”
por: Su, I-Hsuan, et al.
Publicado: (2023)

Adjuvant chemotherapy in carcinoma colon: Is there a rationale to change practice for Asian patients?
por: Rangarajan, Bharath, et al.
Publicado: (2013)

Prediction of neoadjuvant chemotherapy response in breast cancer
por: Myllys, Maiju
Publicado: (2021)

Role of WDR5 in breast cancer prognosis
por: Stoeber, Regina
Publicado: (2019)

Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy?
por: Lee, Jeonghui, et al.
Publicado: (2011)

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?
por: Dalm, Simone U., et al.
Publicado: (2017)

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?
por: Monfardini, S, et al.
Publicado: (2012)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
por: Vauthey, J-N, et al.
Publicado: (2012)

Timely surgical treatment and early prognosis of COVID-19 infection in patients with intertrochanteric fracture
por: Dezhi, Li, et al.
Publicado: (2022)

Downregulation of miRNA-21 and cancer stem cells after chemotherapy results in better outcome in breast cancer patients
por: Dwivedi, Shailendra, et al.
Publicado: (2022)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer
por: Shiomi, Kazu, et al.
Publicado: (2017)

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
por: Yoshino, T, et al.
Publicado: (2012)

Adjuvant treatment in colorectal cancer
por: Taal, B G, et al.
Publicado: (2002)

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2022)

Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
por: Ma, Sung Jun, et al.
Publicado: (2020)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Aspirin as adjuvant therapy in childhood cancer?
por: Morgan, G
Publicado: (2012)

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy
por: Biesaga, Beata, et al.
Publicado: (2014)

Chemotherapy-Induced or Chemotherapy-Associated? Does Physical Therapy Play a Role in Prevention and/or Management of Peripheral Neurotoxicity and Neuropathy?
por: Kumar, Senthil Paramasivam, et al.
Publicado: (2013)

Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
por: Cha, Yoon Jin, et al.
Publicado: (2022)

Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

Early onset of breast cancer in British black women
por: Cichowska, A, et al.
Publicado: (2008)

Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran
por: Eivazi-Ziaei, Jamal, et al.
Publicado: (2014)

Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer
por: Goldrick, A., et al.
Publicado: (2007)

Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?
por: Nakamura, Rikiya, et al.
Publicado: (2022)

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?
por: LeVasseur, N, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5qmhdd6a1tjuja04fep045557q